top of page

Thank you, CSIRO!

Aries Biotech extends gratitude to CSIRO, Australia's national science agency, for inviting Dr. Angela Boutte, the founder of Aries Biotech, to discuss health initiatives. At Aries Biotech, we believe in the power of collaboration. Being invited as an attendee to CSIRO's discussions is an honor, and allows us to contribute our expertise and insights toward global challenges.

Aries Biotech is a neurological disease and dementia biomarker consulting company that provides guidance, data interpretation, document review, and investor support.

To learn more, visit Aries Biotech at

16 views0 comments

Recent Posts

See All

Are you interested in #biomarkers and #therapeutics for #neurologicaldisease and #brainhealth? Aries Biotech want to hear from you! Your perspective holds immense value for us and we recognize the vit

Revolutionizing Neuroscience and Neurotrauma: Aries Biotech Announces New Services Available to KOLs and Investors Aries Biotechnologies is thrilled to introduce

Amyloid Beta Peptides as Biomarkers of Subconcussion Aries Biotech is pleased to share that a recent publication is now available within the Frontiers - Insights in Neurotrauma: 2021 E-Book. Increased

bottom of page